Ki67_final2.sav (18.29 kB)
Maraviroc intensification of cART in patients with suboptimal immunological recovery: a 48-week, placebo-controlled randomized trial
dataset
posted on 2015-06-02, 19:58 authored by Steven Van lelyveldSteven Van lelyveld, Julia Drylewicz, Maaike Krikke, Ellen Veel, Sigrid Otto, Clemens Richter, Robin Soetekouw, Jan Prins, Kees Brinkman, Jan Willem Mulder, Frank Kroon, Ananja Middel, Jori Symons, Annemarie Wensing, Monique Nijhuis, Jose Borghans, Kiki Tesselaar, Andy HoepelmanFile: Ki67+ CD4 and CD8 T cells.
This SPSS file contains the percentage of Ki67+ CD4 and CD8 T cells at various time points during the MIRS trial.
Please see the 'variable view' of the SPSS file and the 'methods' section of the paper for more information.
We have used SAS software for our analyses.
